Heated legal battle over Monsanto’s controversial herbicide dicamba likely to continue in 2019

dicamba damage
A soybean plant damaged by dicamba. Image: Mark Loux/ Ohio State University Extension

The U.S. Ninth Circuit Court of Appeals dismissed a lawsuit against dicamba [the week of January 7], but left open a door for the plaintiffs to expedite a new lawsuit in 2019.

The original [2017] lawsuit….argued that the EPA’s 2016 registration of XtendiMax [dicamba] for over-the-top use on soybean and cotton fields was unlawful. When that registration ended and EPA renewed the dicamba registration in 2018, Monsanto (now Bayer) and EPA argued that the court should dismiss the lawsuit as moot.

The court agreed, but the panel of judges also ruled that the plaintiffs, National Family Farm Coalition et al., should be allowed to fast-track a new lawsuit based on the new 2018 dicamba registration.

The National Family Farm Coalition et al. filed a new petition against the EPA almost immediately after the court’s ruling. The new petition….asks the Ninth Circuit Court of Appeals to rule that EPA violated its duties under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) and the Endangered Species Act (ESA)….

However, the plaintiffs now face an additional hurdle — the partial government shutdown….The Department of Justice is seeking to postpone any civil litigation….and this dicamba court case has fallen under that scope….

The court’s final ruling….would have a large impact….Industry estimates for dicamba-tolerant Xtend soybean and cotton acreage have reached 60 million acres in 2019, and other dicamba-tolerant crops….are expected to be commercialized in the coming years.

Read full, original article: NINTH CIRCUIT DICAMBA BATTLE LIKELY TO CONTINUE IN 2019

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.